Related Experiment Video
Updated: May 20, 2026

09:51
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
Primary Budd-Chiari syndrome - a single center experience
Joanna Raszeja-Wyszomirska1, Joanna Mieżyńska-Kurtycz, Wojciech Marlicz
1Liver Unit, Pomeranian Medical University, Szczecin, Poland. jorasz@sci.pum.edu.pl
Hepato-Gastroenterology
|July 24, 2012
Summary
Budd-Chiari syndrome (BCS) management requires strict adherence to guidelines. Anticoagulation, TIPS, and liver transplants (OLT) are effective treatments for this rare, potentially lethal condition.
Area of Science:
- Hepatology
- Vascular Medicine
- Thrombosis Research
Background:
- Budd-Chiari syndrome (BCS) is a rare but potentially fatal condition caused by hepatic vein thrombosis.
- Prompt diagnosis and management are critical, as BCS can lead to liver failure within three years if untreated.
Purpose of the Study:
- To retrospectively analyze the diagnostic and therapeutic strategies for Budd-Chiari syndrome.
- To evaluate the outcomes of BCS patients managed between 2004 and 2011.
Main Methods:
- Diagnosis confirmed using contrast CT-angiography and Doppler ultrasound.
- Retrospective analysis of 20 BCS patients managed over an 8-year period.
- Treatment included anticoagulation, Transjugular Intrahepatic Portosystemic Shunt (TIPS), and Orthotopic Liver Transplantation (OLT).
Main Results:
- Myeloproliferative disorders, end-stage liver disease, and protein C deficiency were common causes of BCS.
- The majority of patients received anticoagulation, with some undergoing TIPS or LTx.
- A significant proportion of patients (14/20) were alive and well at least one year post-diagnosis, indicating treatment efficacy.
Conclusions:
- Adherence to diagnostic and therapeutic guidelines is crucial for successful BCS management.
- Anticoagulation, TIPS, and OLT demonstrate efficacy in treating Budd-Chiari syndrome.
- Effective management strategies can significantly improve patient survival and outcomes.
Related Concept Videos
Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...